ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2607

Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Rheumatoid Arthritis Hispanics Exposed to Biomass Smoke

Raymundo Vera-Pineda1, Alberto Cardenas-de La Garza2, Jorge Esquivel-Valerio3, Dionicio A. Galarza-Delgado2, Jose Ramon Azpiri-Lopez4, Iris J. Colunga-Pedraza2, Mario Alberto Garza-Elizondo2 and Jesus Zacarias Villarreal-Pérez5, 1Cardiology., Hospital Universitario, UANL., Monterrey, Mexico, 2Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 3Rheumatology, Hospital Universitario.UANL, Monterrey, Mexico, 4Cardiology, Hospital Universitario, UANL., Monterrey, Mexico, 5Endocrinology, Hospital Universitario, UANL., Monterrey, Mexico

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Anti-CCP antibodies and rheumatoid arthritis (RA), Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Tobacco smoke has been associated to anti-cyclic citrullinated peptide (anti-CCP) antibodies positivity. Recently, in wood-smoke-induced chronic obstructive pulmonary disease (COPD) patients without rheumatoid arthritis (RA), anti-CCP antibody higher titers have been reported than in healthy individuals and tobacco-induced COPD. The anti-CCP and rheumatoid factor (RF) titers have not been examined in rheumatoid arthritis patients with biomass smoke exposure. The objective of the present study is to report the correlation between anti-CCP, IgG, IgM and IgA RF to biomass exposure index (BEI).

Methods:

A cross-sectional study was designed based on a cohort of Hispanic RA patients recruited from September 2014 to April 2015. All fulfilled the 1987 ACR and the 2010 ACR/EULAR classification criteria for RA. Biomass smoke exposure was expressed with the BEI calculated as the average hours of exposure per day multiplied by the number of years. Patients with a minimum exposure of 1 BEI were included. RF and Anti-CCP were measured by ELISA with cutoff points of <5U/mL and <20U/mL respectively. Sample calculation expecting a 0.5 correlation determined the need of at least 30 subjects.

Results:

Out of the 102 patients in the cohort, 46 (44.6%) had a BEI equal to or higher than 1 and were included in the analysis. A total of 41 (89.1%) were women with a mean age of 61.06 ±8.82 years and mean disease duration of 12.47 years ±8.81. None had renal or pulmonary disease at baseline. Activity by DAS28 ESR was 3.69 ±1.50 (moderate activity). The median BEI was 42 (p25=30, p75=80.25). All of the exposure was due to in-house cooking with wood. Anti-CCP positivity was present in 33 (71.7%) with a median titer of 150.10 U/mL (p25=2.74, p75=200). IgG RF was present in 11 (23.9%) at a median titer of 8.88 U/mL (p25=4.31, p75=19.98), IgA in 28 (60.9%) with a mean titer of 79.75 U/mL ±77.93, and IgM in 41 (89.1%) with a median of 112.91 U/mL (p25=67.77, p75=200). Spearman’s rho correlation showed no significant correlation between BEI and anti-CCP (p=0.386, rho= -0.131), IgG RF (p=0.147, rho= -0.217), IgA RF (p=0.501, rho= -0.102) and IgM RF (p=0.874, rho=-0.024). Additionally, no difference was found between exposed and not exposed patients regarding anti-CPP (p=0.715), IgG (p=0.335), IgA (p=0.954) and IgM (p=0.433) RF within the cohort. 

Conclusion:

In this Hispanic cohort of established rheumatoid arthritis patients with moderate disease activity exposed to biomass smoke, no correlation was found between BEI and anti-CCP, IgG RF, IgA RF, or IgM RF.


Disclosure: R. Vera-Pineda, None; A. Cardenas-de La Garza, None; J. Esquivel-Valerio, None; D. A. Galarza-Delgado, None; J. R. Azpiri-Lopez, None; I. J. Colunga-Pedraza, None; M. A. Garza-Elizondo, None; J. Z. Villarreal-Pérez, None.

To cite this abstract in AMA style:

Vera-Pineda R, Cardenas-de La Garza A, Esquivel-Valerio J, Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Garza-Elizondo MA, Villarreal-Pérez JZ. Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Rheumatoid Arthritis Hispanics Exposed to Biomass Smoke [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/anti-cyclic-citrullinated-peptide-antibodies-and-rheumatoid-factor-in-rheumatoid-arthritis-hispanics-exposed-to-biomass-smoke/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anti-cyclic-citrullinated-peptide-antibodies-and-rheumatoid-factor-in-rheumatoid-arthritis-hispanics-exposed-to-biomass-smoke/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology